Vol. 27 No. S2 (2020): The Rise of Immuno-oncology: A new hope
This supplement was made possible through the support of Astra Zeneca, Merck Canada Inc. and Hoffmann-La Roche Limited. The opinions expressed in this material do not necessarily reflect the views of our supporters. Current Oncology is thankful for their support of this project and for their ongoing commitment to research and education in cancer.